Skip to main
PHR

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia is well-positioned to benefit from the favorable tailwinds supporting the patient engagement market, with its integrated platform addressing key challenges in healthcare delivery. The company's emphasis on aggressive pricing strategies and its competitive advantage in the space are key factors driving its success. Although the top-line deceleration and the company's "Rule of 40" objective are concerning, ongoing cost-saving efforts and recent restructuring plans should help boost profitability. With its strong financials and potential for future growth, Phreesia is a promising investment opportunity.

Bears say

Phreesia is facing several challenges that could negatively impact its stock price. These include declining subscription revenues, uncertainty regarding pending litigation, and increasing competition from smaller vendors and well-capitalized players in the healthcare industry. Additionally, the company's heavy reliance on the selling season for most of its business and potential risks such as regulatory changes and provider consolidation could also hinder its growth potential. Despite maintaining a BUY rating, analysts have only set a $14 price target for the stock, citing potential risks to the company's financial performance.

Phreesia Inc (PHR) has been analyzed by 15 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 15 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.